Résultats de recherche

• Agenda of the CHMP meeting 17-20 July 2023

  Jean-Michel Dogne

  17/07/23

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Belgium prepares new Covid-19 vaccine booster campaign

  Jean-Michel Dogne

  25/06/23

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda of the PRAC meeting 5-8 June 2023

  Jean-Michel Dogne

  5/06/23

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Data on COVID-19 Detailed by Researchers at University of Namur (Clinical Performance Evaluation of the Fluorecare? Sars-cov-2 & Influenza A/b & Rsv Rapid Antigen Combo Test In Symptomatic Individuals)

  Jean-Michel Dogne, Jonathan Douxfils & Julien FAVRESSE

  28/04/23

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Study Results from University of Namur Broaden Understanding of Coxsackievirus (Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome)

  Jean-Michel Dogne, Jonathan Douxfils, Francois MULLIER, Julien FAVRESSE & Constant Gillot

  10/01/23

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda of the PRAC meeting 9-12 January 2023

  Jean-Michel Dogne

  9/01/23

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• University of Namur Reports Findings in COVID-19 (Safety monitoring of COVID-19 vaccines: perspective from the European Medicines Agency)

  Jean-Michel Dogne

  30/12/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda of the CHMP meeting 12-15 December 2022

  Jean-Michel Dogne

  12/12/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda of the PRAC meeting 28 November - 1 December 2022

  Jean-Michel Dogne

  29/11/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Reports from Namur Research Institute for Life Sciences (NARILIS) Add New Data to Research in Thrombosis and Haemostasis (Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy ...)

  Romain Siriez, Jonathan Evrard, Julien FAVRESSE, Jean-Michel Dogne, Jonathan Douxfils, Francois MULLIER & Celine BOUVY

  24/11/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Reports from European Medicines Agency Highlight Recent Research in COVID-19 (Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination)

  Jean-Michel Dogne

  24/11/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• The campaign is launched, the figures are going up: should we be revaccinated against Covid-19?

  Jean-Michel Dogne

  7/10/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Unequal Access to Monkeypox Shots Gives Europe Pandemic Flashbacks

  Jean-Michel Dogne

  19/08/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Unequal access to monkeypox shots gives Europe pandemic flashbacks

  Jean-Michel Dogne

  18/08/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Unequal Access to Monkeypox Shots Gives Europe Pandemic Flashbacks

  Jean-Michel Dogne

  17/08/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Unequal Access to Monkeypox Shots Gives Europe Pandemic Flashbacks

  Jean-Michel Dogne

  17/08/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda - PRAC draft agenda of meeting 2-5 May 2022

  Jean-Michel Dogne

  2/05/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Coronavirus vaccine: is the 4th dose useful and for whom?

  Jean-Michel Dogne

  16/04/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda - PRAC draft agenda of meeting 4-7 April 2022

  Jean-Michel Dogne

  4/04/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda - CHMP agenda of the 24-27 January 2022 meeting

  Jean-Michel Dogne

  24/01/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• The 10 reasons to hope that 2022 marks the end of the Covid-19 epidemic

  Jean-Michel Dogne

  5/01/22

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• At 62 years old, Anne “suffers from collagenosis” and thinks that she cannot receive the anti-covid vaccine: “I have too much immunity”

  Jean-Michel Dogne

  3/01/22

  2 éléments de Couverture média

  Presse/Médias: Commentaire d'expert

• “The policies are not in the pay of the pharmaceutical industries”, assures Jean-Michel Dogné

  Jean-Michel Dogne

  3/12/21

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Agenda - PRAC draft agenda of meeting 25-28 October 2021

  Jean-Michel Dogne

  25/10/21

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert

• Does the vaccine reduce the risk of coronavirus transmission? Here are the results of a study by Sciensano

  Jean-Michel Dogne

  30/08/21

  1 élément de Couverture média

  Presse/Médias: Commentaire d'expert